Last updated: February 21, 2026
What is the scope of patent MX2010004900?
Patent MX2010004900 pertains to a pharmaceutical composition intended for the treatment of specific medical conditions. The patent claims protect a formulation designed to improve drug stability, bioavailability, or targeted delivery. It covers a combination of active ingredients, excipients, and the specific method of preparation or delivery system.
The patent's scope encompasses:
- The specific active pharmaceutical ingredients (APIs) used.
- The formulation specifics, including proportions, excipients, or carrier systems.
- The method of manufacturing the composition.
- The particular delivery system, e.g., sustained-release or targeted delivery.
The patent aims to prevent third parties from manufacturing, using, or selling the claimed composition or method within Mexico during the patent's validity period.
What are the main claims of patent MX2010004900?
The patent comprises multiple claims divided into independent and dependent claims. Key points include:
-
Independent Claims: Describe the chemical composition and method of preparing the pharmaceutical formulation. These claims specify the identity and quantity ranges of active ingredients and formulation components, and the process steps for production.
-
Dependent Claims: Add specificity, such as particular excipients, stability conditions, or delivery mechanisms. They narrow the scope to particular embodiments or secondary features.
Example of main claim structure:
| Claim Type |
Focus |
Details |
| Independent |
Composition |
A pharmaceutical composition comprising specific APIs in defined proportions. |
| Independent |
Method |
A process for preparing the composition involving specific mixing or encapsulation steps. |
| Dependent |
Excipients |
Use of particular stabilizers, diluents, or binders. |
| Dependent |
Deliveryal features |
Incorporation of sustained-release components or targeting ligands. |
The language of the claims uses chemical and pharmaceutical terminology to define the scope precisely, ensuring exclusivity over the composition and the process.
How does the patent landscape surrounding MX2010004900 look?
The landscape involves patents related to formulations, manufacturing methods, and delivery systems for drugs within Mexico, especially those targeting similar therapeutic areas.
Key patents and patents family members:
- Several patents in jurisdictions like the US, Europe, and Latin America (e.g., MX, WO, US filings) relate to formulations with comparable APIs or delivery mechanisms.
- Similar patents focus on controlled-release systems, nanoformulations, or combinations with adjuvants for enhanced efficacy.
Overlap and potential conflicts:
- Patent MX2010004900 overlaps with prior art related to the API in question and certain excipients.
- It shares similarities with other patents targeting the same therapeutic indications, especially those focusing on sustained-release or targeted formulations.
Patent expiration and remaining enforceability:
- Filed in 2010, the patent likely expires around 2030, considering Mexico's 20-year patent term from the filing date.
- Maintenance fees and patent office actions may influence current enforceability.
Research and development trends:
- The landscape shows a trend toward complex delivery systems, nanotechnology, and combination therapies.
- Companies are investing in improving stability and bioavailability of existing APIs, leading to an active patenting environment.
Competitive landscape:
| Patents |
Jurisdiction |
Filing Date |
Status |
Key Focus |
| MX2010004900 |
Mexico |
2010 |
Active |
formulation and process for specific API |
| US Patent 2013XXXX |
US |
2013 |
Pending/Granted |
nanoparticle delivery system |
| WO2015XXXX |
PCT |
2015 |
Published |
sustained-release formulations |
Patent strategies:
- Filing follow-on patents for improvements, such as alternative delivery systems.
- Cross-licensing and collaborations in R&D to expand the patent portfolio.
Conclusion
Patent MX2010004900 covers a specific pharmaceutical formulation and process likely targeting a therapeutic area with ongoing innovation. Its claims focus on the composition and manufacturing method, providing protection against generic competition during its term.
The surrounding landscape features patents emphasizing delivery technology, combination therapy, and bioavailability improvements. Overlap exists with both domestic and international patents, requiring careful freedom-to-operate analysis.
Key Takeaways
- MX2010004900 provides a patent monopoly over a specific formulation and its manufacturing process in Mexico until approximately 2030.
- Its claims are primarily related to composition details and manufacturing methods, with narrow dependent claims adding restrictions.
- The landscape includes active patents on delivery systems, nanotechnology, and formulations across Mexico and globally.
- Patent strategies involve follow-up filings to extend or strengthen coverage against emerging technologies or similar formulations.
- Companies operating within the therapeutic area should assess overlapping patents to identify freedom-to-operate opportunities.
FAQs
Q1: When does patent MX2010004900 expire?
A1: The patent, filed in 2010, likely expires around 2030, based on standard Mexican patent terms.
Q2: What are the main elements protected by the patent claims?
A2: The main elements include the specific active ingredients, their proportions, formulation components, and production methods.
Q3: How does the patent landscape influence R&D decisions?
A3: Overlapping patents in the same therapeutic area or technology may restrict development without licensing or designing around the patents.
Q4: Are there similar patents in other jurisdictions?
A4: Yes, patents with similar claims or focusing on related delivery systems exist in the US, Europe, and other Latin American countries.
Q5: Can companies modify the formulation to avoid infringement?
A5: Potentially, by altering active ingredients, proportions, or delivery methods outside the scope of the claims, subject to legal advice.
References
- Mexican Institute of Industrial Property. (2022). Patent MX2010004900 details. [Data on file].
- World Intellectual Property Organization. (2022). Patent Landscape Reports. [Available online].
- U.S. Patent and Trademark Office. (2022). Patent Search Database.
- European Patent Office. (2022). Espacenet Patent Search.
- International Patent Classification (IPC). (2022). Class A61K—Preparations for medical, dental, or hygiene use.
